Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients / Esposito, N.; Quintarelli, Concetta; Colavita, I.; Pane, Fabrizio. - In: BLOOD. - ISSN 0006-4971. - ELETTRONICO. - 114:(2009), pp. 871-872.
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients
QUINTARELLI, CONCETTA;PANE, FABRIZIO
2009
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
